SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 67.25 |
| Enterprise Value ($M) | 45.36 |
| Book Value ($M) | 72.96 |
| Book Value / Share | 1.93 |
| Price / Book | 0.92 |
| NCAV ($M) | 46.67 |
| NCAV / Share | 1.24 |
| Price / NCAV | 1.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.76 |
| Return on Assets (ROA) | 0.95 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.26 |
| Current Ratio | 6.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 102.12 |
| Assets | 128.41 |
| Liabilities | 55.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 140.14 |
| Operating Income | 72.67 |
| Net Income | 67.04 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 60.16 |
| Cash from Investing | -34.88 |
| Cash from Financing | -36.72 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Caxton Corp | 0.00 | -100.00 | |
| 13G/A | Stonepine Capital Management, LLC | 3.60 | -51.22 | |
| 13G/A | Avidity Partners Management LP | 9.90 | 13.26 | |
| 13G/A | Federated Hermes, Inc. | 19.99 | 17.88 | |
| 13G/A | Kingdon Capital Management, L.l.c. | 6.02 | 31.82 | |
| 13G/A | Hirschman Orin | 3.50 | -39.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 58,963 | 172,020 | 34.28 | |
| 46,029 | 8,075 | 570.02 | |
| 18,879 | 15,257 | 123.74 | |
| 71,911 | 29,604 | 242.91 | |
| 192,837 | 53,628 | 359.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RWOD – Redwoods Acquisition Corp. | RYTM – Rhythm Pharmaceuticals, Inc. |
| SAGE – Sage Therapeutics, Inc. | SGMT – Sagimet Biosciences Inc. |
| SIGA – SIGA Technologies, Inc. |